Published 12 issues per year
ISSN Print: 1521-9437
ISSN Online: 1940-4344
Indexed in
Efficacy of Cordyceps cicadae (Ascomycota) Mycelium Supplementation for Amelioration of Dry Eye Symptoms: A Randomized, Double-Blind Clinical Pilot Study
ABSTRACT
Dry eye disease (DED), a multifactorial inflammatory ocular surface disorder, affects up to 50% of individuals over 50 years old worldwide and is one of the most common reasons for seeking ophthalmologic care. Generally, topical eye drops or oral drugs are administered to treat DED; however, the use of preservatives in eye drops or the adverse effects of oral drugs are disadvantageous for long-term therapy. Cordyceps cicadae, a traditional Chinese medicinal fungus, possesses anti-inflammatory effects without evident toxicity and is obtainable at low price. Our previous study demonstrated that C. cicadae mycelium effectively ameliorates dry eye symptoms in the benzalkonium chloride (BAC)-induced mouse dry eye model by increasing tear volume and tear film breakup time (TBUT). However, the effects of C. cicadae mycelium for human dry eye amelioration remains unknown. Thus, the present study investigated the mitigation of dry eye conditions and related discomforts through oral supplementation of fermented C. cicadae mycelium. A total of 70 healthy individuals were recruited and randomly allocated to receive a daily oral dose of 1,050 mg preparation in sachet containing either freeze-dried C. cicadae mycelium powder with 0.3 mg of adenosine and 1.5 mg of HEA per gram or placebo for 90 days. The participants were subjected to anthropometric measurements, dry eye questionnaires (DEQ), Schirmer's tests, intraocular pressure (IOP) measurements, tear film breakup time (TBUT) tests, tear osmolality measurements, and tear electrolyte analysis prior to and right after completion of the study. The results showed a significantly increased TBUT as well as a significant decrease in tear osmolarity, in parallel with the decrease of tear electrolytes, especially Na+ and Cl ions. Although significant increase of tear volume was not observed, the increased TBUT suggests mitigation of dry eye through improvement of tear quality. Therefore, C. cicadae mycelium supplementation may be used for dry eye alleviation as a novel therapeutic intervention.
-
Javadi MA, Feizi S. Dry eye syndrome. J Ophthalmic Vis Res. 2011;6:192-8.
-
Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, Viso E, Vitale S, Jones L. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15:334-65.
-
Farrand KF, Fridman M, Stillman IO, Schaumberg DA. Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol. 2017;182:90-8.
-
Gayton JL. Etiology, prevalence and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405-12.
-
Han SB, Hyon JY, Woo SJ, Lee JJ, Kim TH, Kim KW. Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol. 2011;129:633-8.
-
Kuo YK, Lin IC, Chien LN, Lin TY, How YT, Chen KH, Dusting GJ, Tseng CL. Dry eye disease: A review of epidemiology in Taiwan, and its clinical treatment and merits. J Clin Med. 2019;8:1227.
-
Zhong JY, Lee YC, Hsieh CJ, Tseng CC, Yiin LM. Association between dry eye disease, air pollution and weather changes in Taiwan. Int J Environ Res Public Health. 2018;15:2269.
-
Ohashi Y, Ishida R, Kojima T, Goto E, Matsumoto Y, Watanabe K, Ishida N, Nakata K, Takeuchi T, Tsubota K. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol. 2003;136:291-9.
-
Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol. 2001;45:S203-S210.
-
Horng CT, Yang YL, Chen CC, Huang YS, Chen C, Chen FA. Intraocular pressure-lowering effect of Cordyceps cicadae mycelia extract in a glaucoma rat model. Int J Med Sci. 2021;18(4):1007.
-
Weng SC, Chou CJ, Lin LC, Tsai WJ, Kuo YC. Immunomodulatory functions of extracts from the Chinese medicinal fungus Cordyceps cicadae. J Ethnopharmacol. 2002;83:79-85.
-
Zhu R, Zheng R, Deng Y, Chen Y, Zhang S. Ergosterol peroxide from Cordyceps cicadae ameliorates TGF-pi-induced activation of kidney fibroblasts. Phytomedicine. 2014;21:372-8.
-
Wen YT, Jhou BY, Hsu JH, Fu HI, Chen YL, Shih YC, Chen CC, Tsai RK. Neuroprotective effects of Cordyceps cicadae (Ascomycetes) mycelium extract in the rat model of optic nerve crush. Int J Med Mushrooms. 2022;24(2):41-8.
-
Lin TY, Chang HH, Tang YJ, Chen CC, Lee LY, Lin PC. Fermented Cordyceps cicadae mycelia extracts ameliorate dry eye symptoms through reduction of cornea epithelial cell apoptosis and maintenance of conjunctival goblet cells in a mouse dry eye model. J Food Nutr Res. 2017;5:320-30.
-
Achtsidis V, Kozanidou E, Bournas P, Tentolouris N, Theodossiadis PG. Dry eye and clinical disease of tear film, diagnosis and management. Eur Ophthalmic Rev. 2014;8(1):17-22.
-
Akowuah PK, Adjei-Anang J, Nkansah EK, Fummey J, Osei-Poku K, Boadi P, Frimpong AA. Comparison of the performance of the dry eye questionnaire (DEQ-5) to the ocular surface disease index in a non-clinical population. Cont Lens Anterior Eye. 2021;101441.
-
Toth M, Drugovic S. Dry eye assessment-comparison of questionnaires and objective tests. Poster presented at: Optometry and Optics for Better Vision. 2018 May 11-13; Croatia.
-
Tsai YS, Hsu JH, Lin DP, Chang HH, Chang WJ, Chen YL, Chen CC. Safety assessment of HEA-enriched Cordyceps cicadae mycelium: A randomized clinical trial. J Am Coll Nutr. 2021 Feb 17;40(2):127-32.
-
Ayaki M, Negishi K. Decrease of tear break-up time at Japanese eye clinics during five consecutive years. Sci Rep. 2022 Apr 27;12(1):1-7.
-
Kumar N, Feuer W, Lanza NL, Galor A. Seasonal variation in dry eye. Ophthalmology. 2015;122:1727-9.
-
The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international dry eye workshop. Ocul Surf. 2007;5:75-92.
-
Potvin R, Makari S, Rapuano CJ. Tear film osmolality and dry eye disease: A review of the literature. Clin Ophthalmol. 2015;9:2039.
-
Stahl U, Willcox M, Stapleton F. Osmolality and tear film dynamics. Clin Exp Optom. 2012;95:3-11.
-
Woodward AM, Senchyna M, Argueso P. Differential contribution of hypertonic electrolytes to corneal epithelial dysfunction. Exp Eye Res. 2012;100:98.
-
Yang Q, Zhang Y, Liu X, Wang N, Song Z, Wu K. A comparison of the effects of benzalkonium chloride on ocular surfaces between C57BL/6 and BALB/c mice. Int J Mol Sci. 2017;18:509-20.
-
Mohamed HB, Abd El-Hamid BN, Fathalla D, Fouad EA. Current trends in pharmaceutical treatment of dry eye disease: A review. Eur J Pharm Sci. 2022 May 11:106206.
-
Lu MY, Chen CC, Lee LY, Lin TW, Kuo CF. N6-(2-hydroxyethyl) adenosine in the medicinal mushroom Cordyceps cicadae attenuates lipopolysaccharide-stimulated pro-inflammatory responses by suppressing TLR4-Mediated NF-kB signaling pathways. J Nat Prod. 2015;78:2452-60.
-
Zhang L, Wu T, Olatunji OJ, Tang J, Wei Y, Ouyang Z. N6-(2-hydroxyethyl)-adenosine from Cordyceps cicadae attenuates hydrogen peroxide induced oxidative toxicity in PC12 cells. Metab Brain Dis. 2019;34:1325-34.
-
Lan W, Petznick A, Heryati S, Rifada M, Tong L. Nuclear factor-kB: Central regulator in ocular surface inflammation and diseases. Ocul Surf. 2012;10:137-48.
-
Nebbioso M, Del Regno P, Gharbiya M, Sacchetti M, Plateroti R, Lambiase A. Analysis of the pathogenic factors and management of dry eye in ocular surface disorders. Int J Mol Sci. 2017;18:1764.
-
Jiang YM, Hsu JH, Hsu HC, Lin YC, Kao YC, Lai HM, Chen CC. Antiallergic activity of freeze-dried powder of Cordyceps cicadae mycelium fermentation broth. J Testing Qual Assur. 2020;9:34-9.